Search results
Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View
Zacks via Yahoo Finance· 11 months agoAlkermes ALKS received a final award in its arbitration proceedings with Janssen Pharmaceuticals, a...
Alkermes (ALKS) Q2 Earnings & Revenues Beat Estimates
Zacks via Yahoo Finance· 10 months agoAlkermes (ALKS) reports encouraging second-quarter results, wherein both earnings and revenues beat...
Bristol Myers (BMY) Thrombosis Drug Gets Fast Track Designation
Zacks via Yahoo Finance· 12 months agoBristol Myers (BMY) obtains Fast Track Designation from the FDA for milvexian, which is being...
Johnson & Johnson is ditching its script logo for all-new design after 136 years
KREX articles via Yahoo News· 8 months ago(AP) – Johnson & Johnson is signing off on a new logo. The health care giant said Thursday that it...
JnJ news: New Brunswick company dumps iconic script logo for 'new era'
App.com | Asbury Park Press via Yahoo Finance· 8 months agoNEW BRUNSWICK - Johnson & Johnson, the New Jersey health care giant with a storied history,...
Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J...
Fortune via Yahoo Finance· 7 months agoThis week’s episode of Fortune‘s Leadership Next podcast features two conversations from the 2023...
MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results
GuruFocus.com via Yahoo Finance· 5 days agoRevenue: Reported at $0.7 million for Q1 2024, a significant decrease from $3.3 million in Q1 2023,...
Alkermes (ALKS) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 10 months agoAlkermes ALKS is scheduled to report second-quarter 2023 results on Jul 26. Its earnings surprise...
Will Bristol Myers (BMY) Gain From New Drugs' Label Expansion?
Zacks via Yahoo Finance· 1 year agoBristol-Myers Squibb BMY has recently been enjoying a string of positive regulatory updates. The...
Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS
Yahoo Finance· 9 months agoLawsuits brought by big pharmaceutical companies and industry lobbying groups are unlikely to delay...